Biontech: Warum die Gründer Uğur Şahin und Özlem Türeci wirklich gegangen sind Der Spiegel 15:27 Fri, 01 May
BioNTech to Report First Quarter 2026 Financial Results and Corporate Update on May 5, 2026 BioNTech (Press Release) 11:50 Tue, 21 Apr
BioNTech and DualityBio report positive data for trastuzumab pamirtecan Hospital Management 11:30 Mon, 13 Apr
BioNTech and DualityBio’s Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer BioNTech (Press Release) 12:10 Sat, 11 Apr
Biontech-Gründer Türeci und Sahin: Top-Investoren umwerben neues Projekt – ohne es zu kennen Der Tagesspiegel 18:04 Mon, 06 Apr
